BREAKING
Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 26 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 5 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 26 minutes ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 3 hours ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 5 hours ago Earnings Summary: Becton, Dickinson and Company Q1 FY26 adjusted earnings decline 15% 5 hours ago Earnings Summary: Highlights of Apollo Global Management’s (APO) Q4 FY25 report 6 hours ago Earnings Summary: Loews Corporation reports sharp increase in Q4 FY25 profit 7 hours ago Plains All American weakens as NGL divestiture and cost cuts frame muted 2026 growth 9 hours ago Plains All American Streamlines, Targets Crude Growth Amid NGL Exit 9 hours ago Operational Efficiency Powers MGY to Historic Production and Dividend Lift 10 hours ago Johnson Outdoors Hooks 31% Revenue Gain, Operating Loss Narrows 10 hours ago
ADVERTISEMENT
Market News

MannKind Corporation (MNKD): Q4 2019 Earnings Snapshot

— MannKind Corporation (NASDAQ: MNKD) reported Q4 2019 loss of $0.07 per share, vs. a loss of $0.07 expected. — Total revenue amounted to $16 million, vs. $15 million expected. — Afrezza net revenue grew 35% to $7.8 million. — Collaborations and services revenue fell 20% to $8.2 million. — Research and development expenses increased […]

$MNKD February 25, 2020 1 min read
Earnings Update by AlphaStreet

— MannKind Corporation (NASDAQ: MNKD) reported Q4 2019 loss of $0.07 per share, vs. a loss of $0.07 expected.

— Total revenue amounted to $16 million, vs. $15 million
expected.

— Afrezza net revenue grew 35% to $7.8 million.

— Collaborations and services revenue fell 20% to $8.2
million.

— Research and development expenses increased 82% to $2 million.

ADVERTISEMENT

— Cash, cash equivalents, restricted cash and short-term
investments at December 31, 2019 was $50.2 million.

— MNKD shares gained 3.9% immediately following the
announcement.

Get access to timely and accurate verbatim transcripts that are published within hours of the event.

ADVERTISEMENT